Structures by: Kraus W.
Total: 40
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0524(2)Å b=16.3826(5)Å c=23.4238(7)Å
α=90° β=90° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=5.9874(5)Å b=16.1056(15)Å c=23.4443(19)Å
α=90° β=90.04(2)° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0018(6)Å b=16.139(2)Å c=23.448(3)Å
α=90.000(7)° β=90.032(7)° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0587(3)Å b=16.4386(10)Å c=23.3475(14)Å
α=90° β=90° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.1145(2)Å b=17.2901(6)Å c=22.4334(8)Å
α=90° β=90° γ=90°
C23H27BF2N2O
C23H27BF2N2O
The Analyst (2013) 138, 1 325-332
a=10.5132(16)Å b=10.5783(16)Å c=19.315(2)Å
α=90.00° β=97.647(9)° γ=90.00°
C33H14BF19N2
C33H14BF19N2
Organic & biomolecular chemistry (2015) 13, 12 3787-3791
a=10.9506(5)Å b=19.9674(9)Å c=15.2675(9)Å
α=90.00° β=110.711(2)° γ=90.00°
C31H16BF13N2
C31H16BF13N2
Organic & biomolecular chemistry (2015) 13, 12 3787-3791
a=7.3337(12)Å b=9.9719(16)Å c=10.1280(16)Å
α=93.269(5)° β=99.210(5)° γ=110.524(4)°
C24H28BrN6O2ReS3
C24H28BrN6O2ReS3
Dalton Transactions (2008) 24 3215-3225
a=7.806(11)Å b=11.379(19)Å c=16.234(17)Å
α=91.294(19)° β=91.37(3)° γ=105.35(2)°
4(C12H14N3O5Re),H2O,0.5(H2O),0.5(H2O)
4(C12H14N3O5Re),H2O,0.5(H2O),0.5(H2O)
Dalton Transactions (2008) 24 3215-3225
a=11.3584(15)Å b=14.756(2)Å c=19.845(2)Å
α=88.445(11)° β=88.414(10)° γ=76.384(12)°
C6H23Cl4N3O26Th
C6H23Cl4N3O26Th
Dalton transactions (Cambridge, England : 2003) (2012) 41, 41 12818-12823
a=5.447(2)Å b=23.764(11)Å c=20.260(9)Å
α=90.00° β=91.882(11)° γ=90.00°
C24H60Cl3N15O62Th6
C24H60Cl3N15O62Th6
Dalton transactions (Cambridge, England : 2003) (2012) 41, 41 12818-12823
a=27.424(5)Å b=16.084(2)Å c=23.826(4)Å
α=90.00° β=123.258(8)° γ=90.00°
C5H24Na6O27U
C5H24Na6O27U
Dalton transactions (Cambridge, England : 2003) (2010) 39, 15 3744-3750
a=9.563(2)Å b=9.901(2)Å c=13.658(3)Å
α=90.452(3)° β=104.692(3)° γ=95.427(3)°
C22H41CuN5O12
C22H41CuN5O12
Dalton transactions (Cambridge, England : 2003) (2013) 42, 17 6142-6148
a=17.319(13)Å b=15.007(13)Å c=21.514(17)Å
α=90.00° β=90.00° γ=90.00°
C22H40N4O8,5(H2O)
C22H40N4O8,5(H2O)
Dalton transactions (Cambridge, England : 2003) (2013) 42, 17 6142-6148
a=7.833(10)Å b=9.223(12)Å c=11.953(16)Å
α=106.960(14)° β=105.082(13)° γ=100.538(14)°
[2-Carboxy-2,2,2''-nitrilotris(ethanethiolato)- κ^4^N,S,S',S''](triphenylphosphine-κP)rhenium(III) acetone solvate
C25H27NO2PReS3,C3H6O
Acta Crystallographica Section E (2005) 61, 7 m1373-m1375
a=9.624(6)Å b=12.811(7)Å c=13.392(9)Å
α=112.231(5)° β=96.527(6)° γ=90.078(6)°
Bromotricarbonyl{15-[2-(methylsulfanyl)ethylsulfanyl]pentadecanoic acid-κ^2^S,S}rhenium(I)
C21H36BrO5ReS2
Acta Crystallographica Section E (2006) 62, 7 m1660-m1662
a=7.486(5)Å b=12.041(8)Å c=29.07(2)Å
α=90.00° β=90.349(16)° γ=90.00°
Tetrabutylammonium bis(2-amidobenzenethiolato-κ^2^S,N)oxorhenate(V)
C16H36N,C12H10N2OReS2
Acta Crystallographica Section E (2006) 62, 6 m1197-m1199
a=11.821(5)Å b=15.426(6)Å c=17.145(7)Å
α=90.00° β=90.00° γ=90.00°
Hexapotassium dihydrogen monotitanoundecatungstocobaltate(II) tridecahydrate
H28CoK6O53TiW11
Acta Crystallographica, Section E (2005) 61, 3 i35-i37
a=10.6850(16)Å b=10.6850(16)Å c=10.6850(16)Å
α=90.00° β=90.00° γ=90.00°
(4-Methoxybenzenethiolato-κS)oxido[2,2-(propylimino)bis(ethanethiolato)- κ^3^S,N,S']rhenium(V)
C14H22NO2ReS3
Acta Crystallographica Section E (2007) 63, 12 m3018-m3018
a=12.160(3)Å b=16.809(4)Å c=9.441(2)Å
α=90.00° β=111.459(4)° γ=90.00°
(4-methoxybenzenethiolato-κS)oxido[2,2-(3- phenylpropylimino)bis(ethanethiolato)-κ^3^S,N,S']technetium(V)
C21H28NO2S3Tc
Acta Crystallographica Section C (2007) 63, 12 m579-m582
a=10.885(7)Å b=7.247(4)Å c=14.885(7)Å
α=90.00° β=100.913(8)° γ=90.00°
(4-methoxybenzenethiolato-κS)oxido[2,2-(propylimino)bis(ethanethiolato)- κ^3^S,N,S']technetium(V)
C14H22NO2S3Tc
Acta Crystallographica Section C (2007) 63, 12 m579-m582
a=10.610(7)Å b=10.356(7)Å c=16.296(11)Å
α=90.00° β=90.574(15)° γ=90.00°
(3<i>S</i>)-14,16-Dihydroxy-3-methyl-3,4,5,6,9,10,11,12-octahydro-1<i>H</i>-2- benzoxacyclotetradecine-1,7(8<i>H</i>)-dione monohydrate
C18H24O5,H2O
Acta Crystallographica Section E (2012) 68, 5 o1577
a=8.2727(11)Å b=24.579(3)Å c=9.3703(14)Å
α=90.00° β=90.00° γ=90.00°
Isopropyl 2,3,4,6-tetra-<i>O</i>-acetyl-β-<i>D</i>-glucopyranoside
C17H26O10
Acta Crystallographica Section E (2013) 69, 2 o157
a=9.4225(12)Å b=9.9313(12)Å c=11.3641(15)Å
α=90.00° β=98.482(9)° γ=90.00°
<i>n</i>-Propyl 2,3,4,6-tetra-<i>O</i>-acetyl-β-<i>D</i>-glucopyranoside
C17H26O10
Acta Crystallographica Section E (2013) 69, 2 o158
a=7.0072(11)Å b=15.215(3)Å c=19.579(3)Å
α=90.00° β=90.00° γ=90.00°
(3<i>S</i>,7<i>R</i>)-7,14,16-Trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12- decahydro-1<i>H</i>-2-benzoxacyclotetradecin-1-one.
C18H26O5
Acta Crystallographica Section E (2012) 68, 11 o3071
a=5.0734(11)Å b=11.618(2)Å c=14.718(3)Å
α=87.388(13)° β=86.595(15)° γ=89.780(15)°
1-(4-Bromo-3,5,5,6,8,8-hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethan-1-one
C18H25BrO
Acta Crystallographica Section E (2013) 69, 4 o545
a=35.007(8)Å b=19.760(5)Å c=24.826(10)Å
α=90.00° β=127.681(6)° γ=90.00°
H38N9Na3O44S10U2
H38N9Na3O44S10U2
Inorganic Chemistry (2008) 47, 1634-1638
a=9.4995(16)Å b=9.8903(16)Å c=12.744(2)Å
α=93.669(2)° β=103.846(2)° γ=109.339(2)°
C30H56N5O5ReS4
C30H56N5O5ReS4
Inorganic Chemistry (2005) 44, 9930-9937
a=16.754(14)Å b=20.074(17)Å c=25.08(2)Å
α=90.00° β=90.00° γ=90.00°
C31H60N5O6ReS4
C31H60N5O6ReS4
Inorganic Chemistry (2005) 44, 9930-9937
a=10.576(6)Å b=12.616(7)Å c=16.991(9)Å
α=98.539(11)° β=97.841(11)° γ=108.967(10)°
C29H31Cl4N2P2Tc
C29H31Cl4N2P2Tc
Inorganic Chemistry (2004) 43, 8617-8625
a=12.310(2)Å b=17.708(3)Å c=15.197(2)Å
α=90.00° β=109.65(1)° γ=90.00°
C30H31Cl2N2P2STc
C30H31Cl2N2P2STc
Inorganic Chemistry (2004) 43, 8617-8625
a=12.161(2)Å b=10.814(2)Å c=24.676(5)Å
α=90.00° β=101.93(3)° γ=90.00°
C29.5H33Cl2N2O0.5P2Re
C29.5H33Cl2N2O0.5P2Re
Inorganic Chemistry (2004) 43, 8617-8625
a=13.981(3)Å b=12.127(2)Å c=18.355(4)Å
α=90.00° β=95.31(3)° γ=90.00°
C10H14Ce6N12O54
C10H14Ce6N12O54
Inorganic Chemistry (2013) 52, 11734-11743
a=12.3752(17)Å b=26.152(3)Å c=15.698(3)Å
α=90.00° β=90.00° γ=90.00°
C3H3CeO6
C3H3CeO6
Inorganic Chemistry (2013) 52, 11734-11743
a=10.706(2)Å b=10.706(2)Å c=4.1205(12)Å
α=90.00° β=90.00° γ=120.00°
C10H14Ce6N2O46.5
C10H14Ce6N2O46.5
Inorganic Chemistry (2013) 52, 11734-11743
a=12.3326(10)Å b=19.5209(16)Å c=18.9260(16)Å
α=90.00° β=108.313(4)° γ=90.00°
C48H72O81Zr12
C48H72O81Zr12
Inorganic Chemistry (2017)
a=12.605(2)Å b=12.605(2)Å c=13.626(3)Å
α=90.00° β=90.00° γ=90.00°
Zeunerite
As2CuH12.656O24U2
Zeitschrift fur Kristallographie (2003) 218, 37-45
a=7.1751Å b=7.1751Å c=20.8728Å
α=90° β=90° γ=90°
Metazeunerite
AsCu0.5H8O10U
Zeitschrift fur Kristallographie (2003) 218, 37-45
a=7.1065Å b=7.1065Å c=8.7095Å
α=90° β=90° γ=90°
Metazeunerite
AsCu0.5H4O10U
Zeitschrift fur Kristallographie (2003) 218, 37-45
a=7.1065Å b=7.1065Å c=17.4195Å
α=90° β=90° γ=90°